The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive ...
David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...
More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.
Eli Lilly is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage trial by ...
The weight-loss drug boom has transformed Eli Lilly (LLY), the maker of Zepbound, into the largest healthcare company in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback